These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18283109)

  • 1. Nuclear polyglutamine-containing protein aggregates as active proteolytic centers.
    Chen M; Singer L; Scharf A; von Mikecz A
    J Cell Biol; 2008 Feb; 180(4):697-704. PubMed ID: 18283109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-induced cell culture models for degenerative protein aggregation diseases.
    Chen M; von Mikecz A
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():110-4. PubMed ID: 19558242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein.
    Fu L; Gao YS; Sztul E
    Neurobiol Dis; 2005 Dec; 20(3):656-65. PubMed ID: 15964198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
    Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
    J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus.
    von Mikecz A; Chen M; Rockel T; Scharf A
    Methods Mol Biol; 2008; 463():191-202. PubMed ID: 18951170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components.
    Stenoien DL; Mielke M; Mancini MA
    Nat Cell Biol; 2002 Oct; 4(10):806-10. PubMed ID: 12360291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
    Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
    Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions.
    Schmidt T; Lindenberg KS; Krebs A; Schöls L; Laccone F; Herms J; Rechsteiner M; Riess O; Landwehrmeyer GB
    Ann Neurol; 2002 Mar; 51(3):302-10. PubMed ID: 11891825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release.
    Jana NR; Zemskov EA; Wang Gh ; Nukina N
    Hum Mol Genet; 2001 May; 10(10):1049-59. PubMed ID: 11331615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone.
    Park SH; Kukushkin Y; Gupta R; Chen T; Konagai A; Hipp MS; Hayer-Hartl M; Hartl FU
    Cell; 2013 Jul; 154(1):134-45. PubMed ID: 23791384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation.
    Bowman AB; Yoo SY; Dantuma NP; Zoghbi HY
    Hum Mol Genet; 2005 Mar; 14(5):679-91. PubMed ID: 15661755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway.
    Jana NR; Nukina N
    J Chem Neuroanat; 2003 Oct; 26(2):95-101. PubMed ID: 14599658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyglutamine and polyalanine expansions in ataxin7 result in different types of aggregation and levels of toxicity.
    Latouche M; Fragner P; Martin E; El Hachimi KH; Zander C; Sittler A; Ruberg M; Brice A; Stevanin G
    Mol Cell Neurosci; 2006 Mar; 31(3):438-45. PubMed ID: 16325416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.
    Verhoef LG; Lindsten K; Masucci MG; Dantuma NP
    Hum Mol Genet; 2002 Oct; 11(22):2689-700. PubMed ID: 12374759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies.
    Pankiv S; Lamark T; Bruun JA; Øvervatn A; Bjørkøy G; Johansen T
    J Biol Chem; 2010 Feb; 285(8):5941-53. PubMed ID: 20018885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PolyQ fibrillation in the cell nucleus: who's bad?
    von Mikecz A
    Trends Cell Biol; 2009 Dec; 19(12):685-91. PubMed ID: 19796946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PML-nuclear inclusion of human supraoptic neurons: a new compartment with SUMO-1- and ubiquitin-proteasome-associated domains.
    Villagra NT; Navascues J; Casafont I; Val-Bernal JF; Lafarga M; Berciano MT
    Neurobiol Dis; 2006 Jan; 21(1):181-93. PubMed ID: 16125395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.
    Cummings CJ; Reinstein E; Sun Y; Antalffy B; Jiang Y; Ciechanover A; Orr HT; Beaudet AL; Zoghbi HY
    Neuron; 1999 Dec; 24(4):879-92. PubMed ID: 10624951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular localization of proteasomes.
    Wójcik C; DeMartino GN
    Int J Biochem Cell Biol; 2003 May; 35(5):579-89. PubMed ID: 12672451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inefficient degradation of truncated polyglutamine proteins by the proteasome.
    Holmberg CI; Staniszewski KE; Mensah KN; Matouschek A; Morimoto RI
    EMBO J; 2004 Oct; 23(21):4307-18. PubMed ID: 15470501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.